Found: 22
Select item for more details and to access through your institution.
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 7, p. 1013, doi. 10.1093/cid/cix916
- By:
- Publication type:
- Article
Induction of cyclooxygenase-2 by tumor promoters in transformed and cytochrome P450 2E1-expressing hepatocytes.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 1, p. 73, doi. 10.1093/carcin/23.1.73
- By:
- Publication type:
- Article
2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting.
- Published in:
- Insights into Imaging, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13244-021-01090-7
- By:
- Publication type:
- Article
Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1872, doi. 10.1111/liv.15914
- By:
- Publication type:
- Article
Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1728, doi. 10.1001/jama.2015.3860
- By:
- Publication type:
- Article
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 920, doi. 10.1111/apt.17699
- By:
- Publication type:
- Article
Long‐term prognosis of patients with metabolic (dysfunction)‐associated fatty liver disease by non‐invasive methods.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 580, doi. 10.1111/apt.16760
- By:
- Publication type:
- Article
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 12, p. 1862, doi. 10.1038/ajg.2012.331
- By:
- Publication type:
- Article
Prognostic Indices for Budd–Chiari Syndrome: Valid for Clinical Studies but Insufficient for Individual Management.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2009, v. 104, n. 5, p. 1140, doi. 10.1038/ajg.2009.63
- By:
- Publication type:
- Article
TT Virus Infection During Chronic Hepatitis C.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2000, v. 95, n. 7, p. 1765, doi. 10.1111/j.1572-0241.2000.02138.x
- By:
- Publication type:
- Article
Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047715
- By:
- Publication type:
- Article
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 4, p. 848, doi. 10.1111/jgh.13219
- By:
- Publication type:
- Article
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1287, doi. 10.1001/jama.2024.1447
- By:
- Publication type:
- Article
Actualités sur le virus de l'hépatite Delta.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 5, doi. 10.1684/hpg.2022.2366
- By:
- Publication type:
- Article
Les points-clés à retenir/avis d'experts : du dépistage au traitement de l'hépatite chronique à virus Delta.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 45, doi. 10.1684/hpg.2022.2349
- By:
- Publication type:
- Article
Le FibroScan™ a 20 ans, l'âge de la maturité ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 6, p. 563, doi. 10.1684/hpg.2020.1991
- By:
- Publication type:
- Article
Feasibility of liver transient elastography with FibroScan<sup>®</sup> using a new probe for obese patients.
- Published in:
- Liver International, 2010, v. 30, n. 7, p. 1043, doi. 10.1111/j.1478-3231.2010.02258.x
- By:
- Publication type:
- Article
Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.
- Published in:
- Liver International, 2009, v. 29, n. 2, p. 242, doi. 10.1111/j.1478-3231.2008.01802.x
- By:
- Publication type:
- Article
Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan<sup>®</sup>: A Comparative Study with the M Probe and Liver Biopsy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rapid and large-scale implementation of HCV treatment advances in France, 2007-2015.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy.
- Published in:
- Journal of Medical Virology, 2004, v. 72, n. 1, p. 46
- By:
- Publication type:
- Article
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
- Published in:
- 2020
- By:
- Publication type:
- journal article